Clinical Trials Directory

Trials / Completed

CompletedNCT00972439

Oral Contraceptive (OC) Progestin Dose and Breast Proliferation

Evaluating the Effect of Oral Contraceptive Progestin Dose on Breast Epithelial Cell Proliferation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
Female
Age
18 Years – 34 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill). Some research indicates that women who use birth control pills with lower amounts of progestin (a hormone in the birth control pill) may have lower breast cell growth than women who use birth control pills with a higher amount of progestin; this research will examine that in detail.

Conditions

Interventions

TypeNameDescription
DRUGOral Contraceptive: Ortho-Novum® 1/35
DRUGOral Contraceptive: Ovcon Fe®

Timeline

Start date
2007-08-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2009-09-07
Last updated
2018-02-23
Results posted
2018-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00972439. Inclusion in this directory is not an endorsement.